The expression of tight junction proteins in intestinal wall. by Xueyan Lin (448667)

Subjects:

Alterations in the composition of gut microbiome in phylum and genus. by Xueyan Lin (448667)

Subjects:

Alpha and beta diversity of gut microbiome. by Xueyan Lin (448667)

Subjects:

Differential genera features based on DESeq2 analysis. by Xueyan Lin (448667)

Subjects:

Experimental design. by Xueyan Lin (448667)

Subjects:

The expression of Claudin-1 and ZO-1 in intestinal wall. by Xueyan Lin (448667)

Subjects:

The expression of GABARAP in rat brain tissue by IHC. by Xueyan Lin (448667)

Subjects:

Differences in microbial functions among groups in pathways of KEGG. by Xueyan Lin (448667)

Subjects:

Table 1_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Table 2_Increased frequencies of human Th-17 CD4+ T-cells and decreased T-regulatory cells in patients with early and advanced metabolic dysfunction-associated steatotic liver dise... by Elżbieta Supruniuk (16736637)

Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

“…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”

Representative CEUS images with BR55 of mice with a subcutaneous tumour allograft (arrows) under treatment. by Felix L. Herr (21544362)

Subjects:

Column charts of SI_8min and SI_10min in the therapy and control group at follow-up. by Felix L. Herr (21544362)

Subjects:

Representative immunohistochemical stainings. by Felix L. Herr (21544362)

Subjects:

Experimental design. by Felix L. Herr (21544362)

Subjects:

ROI selection. by Felix L. Herr (21544362)

Subjects:

Column charts of WiAUC in therapy and control group at baseline and follow-up. by Felix L. Herr (21544362)

Subjects:

The Laboratory Animal Flow Diagram. by Xueqin lu (22250795)

“…Additionally, it effectively lowers serum cholesterol levels by as much as 69.2% and low-density lipoprotein cholesterol (LDL-C) levels by up to 88.2% in the MASH mouse model. …”

¹H NMR spectra for kylo-0603. by Xueqin lu (22250795)

“…Additionally, it effectively lowers serum cholesterol levels by as much as 69.2% and low-density lipoprotein cholesterol (LDL-C) levels by up to 88.2% in the MASH mouse model. …”

¹³C NMR spectra for Kylo-0603. by Xueqin lu (22250795)

“…Additionally, it effectively lowers serum cholesterol levels by as much as 69.2% and low-density lipoprotein cholesterol (LDL-C) levels by up to 88.2% in the MASH mouse model. …”